gefitinib has been researched along with asiatic acid in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (asiatic acid) | Trials (asiatic acid) | Recent Studies (post-2010) (asiatic acid) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 289 | 3 | 232 |
| Protein | Taxonomy | gefitinib (IC50) | asiatic acid (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 5.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, B; Hou, XY; Shi, JJ; Zhang, CL; Zhao, CH; Zhao, LX | 1 |
1 other study(ies) available for gefitinib and asiatic acid
| Article | Year |
|---|---|
Design, synthesis, and biofunctional evaluation of novel pentacyclic triterpenes bearing O-[4-(1-piperazinyl)-4-oxo-butyryl moiety as antiproliferative agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Pentacyclic Triterpenes; Piperazines; Structure-Activity Relationship | 2015 |